Oncology

Displaying 1 - 10 of 22


Small Molecule Mediated Transcriptional Induction of E-Cadherin and Inhibition of Epithelial-to-mesenchymal Transition


Licensing Contact

Tom Utley

615.343.3852
Therapeutics
Oncology

Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders

The Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) has a mission to promote the translation of advances in basic science towards novel therapeutics. They have recruited faculty and staff with experience at over 10 different pharmaceutical companies to ensure a diverse set of approaches, techniques and philosophies to advancing compounds. Together they aim to de-risk drug discovery programs.


Licensing Contact

Tom Utley

615.343.3852
Therapeutics

mGlu3 NAMs as Therapeutics for Chemoresistant Tumors

Targeting metabotropic glutamate receptor 3 (mGlu3) has been linked as a potential therapeutic to many neurological disorders and well as oncology through the use of dual specific mGlu2/3 Antagonists (LY341495, RO4491533, MGS0039, RO4988546).


Licensing Contact

Tom Utley

615.343.3852
Therapeutics

Primary Human Fibroblats Derived From Prostate Cancer Tissue and Normal Tissue

This research targets prostate cancer.


Licensing Contact

Karen Rufus

615.322.4295
Research Tools
Cell Line
Oncology

HCC2429 Human Lung Cancer Cell Line

This research targets HCC2429.


Licensing Contact

Karen Rufus

615.322.4295
Research Tools
Cell Line
Oncology

B53 CHO Cell Line with Inducible VDJ Recombinase Expression

This research targets VDJ recombinase.


Licensing Contact

Karen Rufus

615.322.4295

Inventors

Eugene Oltz
Research Tools
Cell Line
Oncology Research Reagent

Screening Assay for Molecules That Alter Cell Cycle Rhythm

This research targets Cell Cycle.


Licensing Contact

Karen Rufus

615.322.4295
Research Tools
Assays/Screening
Oncology Research Reagent

Myc Antigens

This research targets Myc.


Licensing Contact

Mike Villalobos

615.322.6751

Inventors

Stephen Hann
Research Tools
Antibody
Oncology Research Reagent

Mouse Anti-Rabbit Rab25 Monoclonal Antibody

This research targets Rab25.


Licensing Contact

Jody Hankins

615.322.5907

Inventors

James Goldenring
Research Tools
Antibody
Oncology

Anti-p19 ARF Antibody

This research targets ARG(p19).


Licensing Contact

Mike Villalobos

615.322.6751

Inventors

Stephen Hann
Research Tools
Antibody
Oncology